Functional annotation and enrichment analysis of differentially expressed serum proteins in patients with type 2 diabetes after dapagliflozin

Figure 5 Correlation analyses of the expression levels of three differentially expressed proteins and clinical indexes of type 2 diabetic patients. A: The levels of three differentially abundant proteins, including myeloperoxidase (MPO), alpha II B integrin, and podocalyxin (PCX) proteins in serum samples of patients before and after dapagliflozin treatments were evaluated by enzyme linked immunosorbent assay. n = 20 for each group. ^aP < 0.05, ^bP < 0.01, ^cP < 0.001, between the indicated groups; B-D: Dot plots show the Pearson correlations between the levels of alpha II B integrin (B), PCX (C), and MPO (D) proteins and some clinical indexes in patients before and after dapagliflozin treatments.